AADDS Fall Conference

Agenda:

*denotes non-CME activity

8:00 – 8:25 am - Breakfast and Exhibit Viewing

8:25 – 8:30 am – Welcome

8:30 – 9:30 - Finan Templeton Dermpath Cases

9:30 – 10:15 am - Novel and pipeline therapies for Hidradenitis Suppurativa, Haley Naik, MD

10:15 – 10:30am – Q&A

10:30 – 11:00 am – Break/Exhibit Viewing

11:00 – 11:30am – *Non-CME Activity – Bimzelx Has Arrived: Transformative Treatment Results, Jamie Weisman, MD

11:30 - 12:15pm - Management of Hidradenitis Suppurativa in Special Populations, Haley Naik, MD

12:15pm – 12:30pm – Q&A

12:30 – 1:00pm - Break/Lunch/Exhibit Viewing

1:00 – 1:30pm – *Non-CME Activity - Raising The Bar: Exploring higher level endpoints from a head to head study in the treatment of moderate to severe atopic dermatitis, Michael Bernhardt, MD

1:30 – 2:15 pm – Overcoming Barriers to Caring for People with Hidradenitis Suppurativa, Haley Naik, MD

2:15 – 2:25 pm - Q&A

2:25 – 2:30 pm – Closing Remarks

Keynote Speaker Objectives: 
Novel and pipeline therapies for Hidradenitis Suppurativa

1. Summarize current evidence on efficacy and safety of biologic therapy for hidradenitis suppurativa
2. Evaluate late-breaking evidence supporting the use of novel therapies for hidradenitis suppurativa 
3. Articulate current gaps in knowledge regarding HS and evaluate the approaches being utilized to address them

Management of Hidradenitis Suppurativa in Special Populations

1. Summarize the current evidence on efficacy and safety of hidradenitis suppurativa therapies for pediatric and adolescent individuals
2. Summarize the current evidence on efficacy and safety of hidradenitis suppurativa therapies for pregnant individuals
3. Summarize the current evidence on efficacy and safety of hidradenitis suppurativa therapies for individuals with chronic infections and other chronic conditions